img

Global BCG Vaccine for Intradermal Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global BCG Vaccine for Intradermal Injection Market Research Report 2024

According to Mr Accuracy reports’s new survey, global BCG Vaccine for Intradermal Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole BCG Vaccine for Intradermal Injection market research.
Key manufacturers engaged in the BCG Vaccine for Intradermal Injection industry include Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, Intervax and GSBPL, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of BCG Vaccine for Intradermal Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole BCG Vaccine for Intradermal Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global BCG Vaccine for Intradermal Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Sanofi Pasteur
Japan BCG Lab
Shanghai Institute of Biological Products
Serum Institute of India
Intervax
GSBPL
Segment by Type
BCG for Immunization
BCG for Therapy

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The BCG Vaccine for Intradermal Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 BCG Vaccine for Intradermal Injection Market Overview
1.1 Product Overview and Scope of BCG Vaccine for Intradermal Injection
1.2 BCG Vaccine for Intradermal Injection Segment by Type
1.2.1 Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2024-2034)
1.2.2 BCG for Immunization
1.2.3 BCG for Therapy
1.3 BCG Vaccine for Intradermal Injection Segment by Application
1.3.1 Global BCG Vaccine for Intradermal Injection Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global BCG Vaccine for Intradermal Injection Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine for Intradermal Injection Revenue 2024-2034
1.4.2 Global BCG Vaccine for Intradermal Injection Sales 2024-2034
1.4.3 Global BCG Vaccine for Intradermal Injection Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 BCG Vaccine for Intradermal Injection Market Competition by Manufacturers
2.1 Global BCG Vaccine for Intradermal Injection Sales Market Share by Manufacturers (2024-2024)
2.2 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Manufacturers (2024-2024)
2.3 Global BCG Vaccine for Intradermal Injection Average Price by Manufacturers (2024-2024)
2.4 Global BCG Vaccine for Intradermal Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Product Type & Application
2.7 BCG Vaccine for Intradermal Injection Market Competitive Situation and Trends
2.7.1 BCG Vaccine for Intradermal Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BCG Vaccine for Intradermal Injection Players Market Share by Revenue
2.7.3 Global BCG Vaccine for Intradermal Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG Vaccine for Intradermal Injection Retrospective Market Scenario by Region
3.1 Global BCG Vaccine for Intradermal Injection Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global BCG Vaccine for Intradermal Injection Global BCG Vaccine for Intradermal Injection Sales by Region: 2024-2034
3.2.1 Global BCG Vaccine for Intradermal Injection Sales by Region: 2024-2024
3.2.2 Global BCG Vaccine for Intradermal Injection Sales by Region: 2024-2034
3.3 Global BCG Vaccine for Intradermal Injection Global BCG Vaccine for Intradermal Injection Revenue by Region: 2024-2034
3.3.1 Global BCG Vaccine for Intradermal Injection Revenue by Region: 2024-2024
3.3.2 Global BCG Vaccine for Intradermal Injection Revenue by Region: 2024-2034
3.4 North America BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.4.1 North America BCG Vaccine for Intradermal Injection Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034)
3.4.3 North America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine for Intradermal Injection Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2034)
3.5.3 Europe BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.6.1 Asia Pacific BCG Vaccine for Intradermal Injection Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific BCG Vaccine for Intradermal Injection Sales by Country (2024-2034)
3.6.3 Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine for Intradermal Injection Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034)
3.7.3 Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine for Intradermal Injection Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2034)
3.8.3 Middle East and Africa BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2034)
4.1.1 Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2024)
4.1.2 Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2034)
4.1.3 Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2024-2034)
4.2 Global BCG Vaccine for Intradermal Injection Revenue by Type (2024-2034)
4.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Type (2024-2024)
4.2.2 Global BCG Vaccine for Intradermal Injection Revenue by Type (2024-2034)
4.2.3 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2024-2034)
4.3 Global BCG Vaccine for Intradermal Injection Price by Type (2024-2034)
5 Segment by Application
5.1 Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2034)
5.1.1 Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2024)
5.1.2 Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2034)
5.1.3 Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2024-2034)
5.2 Global BCG Vaccine for Intradermal Injection Revenue by Application (2024-2034)
5.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Application (2024-2024)
5.2.2 Global BCG Vaccine for Intradermal Injection Revenue by Application (2024-2034)
5.2.3 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2024-2034)
5.3 Global BCG Vaccine for Intradermal Injection Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck BCG Vaccine for Intradermal Injection Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 Shanghai Institute of Biological Products
6.4.1 Shanghai Institute of Biological Products Corporation Information
6.4.2 Shanghai Institute of Biological Products Description and Business Overview
6.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolio
6.4.5 Shanghai Institute of Biological Products Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Intervax BCG Vaccine for Intradermal Injection Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
6.4.4 GSBPL BCG Vaccine for Intradermal Injection Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine for Intradermal Injection Industry Chain Analysis
7.2 BCG Vaccine for Intradermal Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine for Intradermal Injection Production Mode & Process
7.4 BCG Vaccine for Intradermal Injection Sales and Marketing
7.4.1 BCG Vaccine for Intradermal Injection Sales Channels
7.4.2 BCG Vaccine for Intradermal Injection Distributors
7.5 BCG Vaccine for Intradermal Injection Customers
8 BCG Vaccine for Intradermal Injection Market Dynamics
8.1 BCG Vaccine for Intradermal Injection Industry Trends
8.2 BCG Vaccine for Intradermal Injection Market Drivers
8.3 BCG Vaccine for Intradermal Injection Market Challenges
8.4 BCG Vaccine for Intradermal Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global BCG Vaccine for Intradermal Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global BCG Vaccine for Intradermal Injection Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global BCG Vaccine for Intradermal Injection Sales Market Share by Manufacturers (2024-2024)
Table 6. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global BCG Vaccine for Intradermal Injection Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market BCG Vaccine for Intradermal Injection Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of BCG Vaccine for Intradermal Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Product Type & Application
Table 12. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG Vaccine for Intradermal Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Intradermal Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG Vaccine for Intradermal Injection Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (K Units)
Table 18. Global BCG Vaccine for Intradermal Injection Sales Market Share by Region (2024-2024)
Table 19. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global BCG Vaccine for Intradermal Injection Sales Market Share by Region (2024-2034)
Table 21. Global BCG Vaccine for Intradermal Injection Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2024-2024)
Table 23. Global BCG Vaccine for Intradermal Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2024-2034)
Table 25. North America BCG Vaccine for Intradermal Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 27. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe BCG Vaccine for Intradermal Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 32. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America BCG Vaccine for Intradermal Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 42. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2024)
Table 51. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2034)
Table 52. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2024-2024)
Table 53. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2024-2034)
Table 54. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Type (2024-2024)
Table 55. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2024-2024)
Table 57. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2024-2034)
Table 58. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2024-2024)
Table 59. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Application (2024-2024)
Table 61. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Application (2024-2034)
Table 62. Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2024-2024)
Table 63. Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2024-2034)
Table 64. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Application (2024-2024)
Table 65. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2024-2024)
Table 67. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2024-2034)
Table 68. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2024-2024)
Table 69. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck BCG Vaccine for Intradermal Injection Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Japan BCG Lab BCG Vaccine for Intradermal Injection Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. Shanghai Institute of Biological Products Corporation Information
Table 86. Shanghai Institute of Biological Products Description and Business Overview
Table 87. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product
Table 89. Shanghai Institute of Biological Products Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Serum Institute of India BCG Vaccine for Intradermal Injection Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Intervax Corporation Information
Table 96. Intervax Description and Business Overview
Table 97. Intervax BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Intervax BCG Vaccine for Intradermal Injection Product
Table 99. Intervax Recent Developments/Updates
Table 100. GSBPL Corporation Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. GSBPL BCG Vaccine for Intradermal Injection Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. BCG Vaccine for Intradermal Injection Distributors List
Table 108. BCG Vaccine for Intradermal Injection Customers List
Table 109. BCG Vaccine for Intradermal Injection Market Trends
Table 110. BCG Vaccine for Intradermal Injection Market Drivers
Table 111. BCG Vaccine for Intradermal Injection Market Challenges
Table 112. BCG Vaccine for Intradermal Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of BCG Vaccine for Intradermal Injection
Figure 2. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global BCG Vaccine for Intradermal Injection Market Share by Type in 2022 & 2034
Figure 4. BCG for Immunization Product Picture
Figure 5. BCG for Therapy Product Picture
Figure 6. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global BCG Vaccine for Intradermal Injection Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global BCG Vaccine for Intradermal Injection Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global BCG Vaccine for Intradermal Injection Market Size (2024-2034) & (US$ Million)
Figure 13. Global BCG Vaccine for Intradermal Injection Sales (2024-2034) & (K Units)
Figure 14. Global BCG Vaccine for Intradermal Injection Average Price (US$/Unit) & (2024-2034)
Figure 15. BCG Vaccine for Intradermal Injection Report Years Considered
Figure 16. BCG Vaccine for Intradermal Injection Sales Share by Manufacturers in 2022
Figure 17. Global BCG Vaccine for Intradermal Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest BCG Vaccine for Intradermal Injection Players: Market Share by Revenue in 2022
Figure 19. BCG Vaccine for Intradermal Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global BCG Vaccine for Intradermal Injection Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America BCG Vaccine for Intradermal Injection Sales Market Share by Country (2024-2034)
Figure 22. North America BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2024-2034)
Figure 23. United States BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Country (2024-2034)
Figure 26. Europe BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2024-2034)
Figure 27. Germany BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific BCG Vaccine for Intradermal Injection Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2024-2034)
Figure 34. China BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America BCG Vaccine for Intradermal Injection Sales Market Share by Country (2024-2034)
Figure 42. Latin America BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2024-2034)
Figure 43. Mexico BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Country (2024-2034)
Figure 47. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2024-2034)
Figure 48. Turkey BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. UAE BCG Vaccine for Intradermal Injection Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Global Sales Market Share of BCG Vaccine for Intradermal Injection by Type (2024-2034)
Figure 52. Global Revenue Market Share of BCG Vaccine for Intradermal Injection by Type (2024-2034)
Figure 53. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2024-2034)
Figure 54. Global Sales Market Share of BCG Vaccine for Intradermal Injection by Application (2024-2034)
Figure 55. Global Revenue Market Share of BCG Vaccine for Intradermal Injection by Application (2024-2034)
Figure 56. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2024-2034)
Figure 57. BCG Vaccine for Intradermal Injection Value Chain
Figure 58. BCG Vaccine for Intradermal Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed